Clinical Trial Update: De-Escalation Surgery After Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating de-escalation surgery after immunotherapy for locally advanced head and neck squamous cell carcinoma and is currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 3 | Status: NOT_YET_RECRUITING